This trial will study the impacts of reduced cannabis use on functional outcomes in heavy cannabis users, in order to inform clinical trials of pharmacotherapies for substance use disorders.
4 Primary · 8 Secondary · Reporting Duration: Baseline and post-treatment (approximately eight weeks)
92 Total Participants · 2 Treatment Groups
Primary Treatment: Mobile contingency management · No Placebo Group · N/A
Age 18 - 80 · All Participants · 5 Total Inclusion CriteriaMark “Yes” if the following statements are true for you:
|18 - 65||100.0%|
|Duke University Medical Center||100.0%|